Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 474281 - 474300 out of 483426 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 80MG TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA02) dasatinib (adm: O) | SPRYCEL 80MG TABLETS | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Bristol-MyersSquibbCompany |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 150MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 150MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 200MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 200MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 50MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 50MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 50MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 50MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 100MG TAB | 150 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 100MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 100MG TAB | 150 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 100MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 400MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 400MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 500MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA04) bosutinib (adm: O) | BOSULIF 500MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | Pfizer,Inc. |
| USA | (L01EA05) ponatinib (adm: O) | ICLUSIG 10MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid;Leukemia, Lymphoid | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L01EA05) ponatinib (adm: O) | ICLUSIG 10MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid;Leukemia, Lymphoid | TakedaPharmaceuticalsAmerica,Inc. |
Pages
